Abstract
Technical innovations such as the availability of movable patient platforms and the introduction of 32-channel systems have made whole-body MRI for tumor staging feasible. In addition, the development of dual-modality PET/CT systems offers the opportunity to perform anatometabolic tumor staging with whole-body coverage in a single session. Based on an increase in patient survival when applying a stage-adapted therapy in different malignant diseases the relevant question relates to the accuracies of whole-body MRI and whole-body PET/CT for TNM staging. This review article addresses whole-body tumor staging with MRI and FDG-PET/CT with special emphasis on diagnostic accuracies for staging different malignant diseases.
| Translated title of the contribution | Whole-body tumor staging: MRI or FDG-PET/CT? |
|---|---|
| Original language | German |
| Journal | Radiologe |
| Volume | 44 |
| Issue number | 9 |
| Pages (from-to) | 882-888 |
| Number of pages | 7 |
| ISSN | 0033-832X |
| DOIs | |
| Publication status | Published - 09.2004 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics of 'Whole-body tumor staging: MRI or FDG-PET/CT?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver